Acorda Surges On Study Results for Multiple Sclerosis Drug

Acorda Therapeutics CEO Ron Cohen stopped by last month to talk with us about multiple sclerosis treatments and a drug that his company is developing to help MS patients walk better. He seemed upbeat then about prospects for the company’s drug Fampridine-SR, but he couldn’t give us the details. (You can watch our video interview [...]